chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My hands and my joints were starting to ache. My hands were swollen, and I could not move them first thing in the morning. My hips were painful.  I went in for a routine doctor check about 3 weeks after I got my second dose. They did some blood work and found that I was having problems with inflammation and that my uric acid was really high. They also did nerve tests on my hands and I have recurring carpal tunnel syndrome. I also went to the ER but it was because I had heart palpitations and chest pain and they said it was musculoskeletal and they thought it was an anxiety attack.
Rash with pain and burning sensation located on the arm in a straight line where vaccinated the night of receiving the vaccine. Began to spread along the arm, but nowhere else on the body and develop blisters and redness. Along with rash was constant pain through the whole arm and pain in armpit where lymph node is located.  Went to a healthcare clinic one week later who said it was a possible case of shingles. Took a sample to send to lab. Was prescribed valacyclovir.
This case was reported by a consumer via call center representative and described the occurrence of hives in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced hives. On an unknown date, the outcome of the hives was unknown. It was unknown if the reporter considered the hives to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported, but was selected as adult as per vaccine indication. The caller reported that her target pharmacist told her that they had had many patients experience hives after getting SHINGRIX.
developed hives 3 hours after injection  ,size 1-2cm  lasting  3 days
After first dose experienced bad eye swelling and throat constriction.  Primary clinician advised individual not proceed with second dose at this time.
I had only a mid effect immediately following the vaccine.  But on August 17, I began having severe congestion and sinus pressure headaches.  I was very fatigued and stayed home from work. I had a PCR Covid test at work and it was a positive diagnosis. I met with the health center nurse practitioner and she told me to treat the symptoms as they happened. She gave me Vitamin C, Vitamin D, zinc Glycinate, Quercetin with Bromelain, and NAC Amino Acids to take daily. A nasal spray helped a lot with the congestion.  I took Ibuprofen as needed for the headaches and muscle aches.  I took Benadryl and Claritin for the congestion. I was quarantined from August 17 to 27 and was not able to work except from home. For those weeks and some following, I was mostly very tired and felt like I had a bad cold. I also had "fuzzy" head where I could not focus or concentrate. I was easily distracted. I felt more anxious and needed to sleep a lot. It got better over time, but even now I don't feel like I have all of my energy and stamina back. I still have times when I can't think very well.
This spontaneous report was received from a patient's friend husband referring to a 37 year old male patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On an unknown date, the patient was vaccinated with GARDASIL 9 for prophylaxis (strength, dose, route, lot # and expiration date were not reported). The reporter could not confirm how many doses, in the GARDASIL 9 series, the patient was administered. No adverse event was reported.
Pt developed erythema below site of injection and did not include site of injection. Erythema was circumferential around upper arm and humerous. This developed several hours after administration. Treated for cellulitis.
While administering COVID vaccination syringe and needle became disconnected, resulting in loss of vaccine serum.  Patient received less than half a dose in her left deltoid. This RN consulted with RN clinic supervisor, who consulted the literature and recommended repeating dose. New syringe/needle combination was used to administer a repeat dose in the right deltoid without issue.
Patient began to feel light headed two minutes after receiving HPV vaccine. Patient was reclined in chair, had cold compress applied to forehead and was given a sucker. Vitals were BP - 96/60 and HR 85. Monitored for 10 minutes longer new vitals 102/64 and HR 88 and 107/66 and HR 85. Patient now sitting in chair for 5 minutes and drinking another orange juice. Vitals BP - 116/75 and HR 88. Patient felt well and left. Patient was given orange juice before giving vaccination. Mother also stated patient ate breakfast before coming to office.
This spontaneous report was received from store, via claims examiner concerning a patient of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On an unknown date the patient was vaccinated with PNEUMOVAX (manufacturer unknown), subcutaneous injection, 0.05ml, (strength and anatomical location were not reported) (lot number 1947AA). Other suspect therapies included ZOSTAVAX, (start date of therapy, strength, dose, route and lot number were not reported). On an unknown date the patient was diagnosed with cellulitis after receiving the pneumococcal vaccine (manufacturer unknown). The reported stated that the procedure and items used administering the shot were entirely sterile. Bacterial etiology was believe to be from the vaccine. The outcome of cellulitis was unknown. Additional information has been requested.
bump at injection site; redness at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than 2 weeks after receiving Shingrix, the patient experienced injection site swelling and injection site erythema. In August 2019, the outcome of the injection site swelling and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The caller was the patient's wife.  The patient received Shingrix and developed a bump and redness at the injection site. The caller did not provide any additional information. This case was linked with the case US2019149370, reported for patient's wife.
pt recvd vax & became irritable w/rash of head & upper & lower extremities followed by whelp approx 1-3cm of upper extremities lat abd & back; resp clear-no buccal cyanosis noted; Pt responsive, later pt checked by MD @ office;
Patient complained of a knot that seemed to move near her collar bone that appeared on the left side on the shot side on nov 20. Other symptoms include pain from knot (size of marble) when walking around. no other symptoms
about a week or so after I got a sever burning on my left rib gage that was very itchy, thought it might be Shingles but I've had the shot.  I disappeared after a few days.  Then I got s similar reaction after my second shot that was on my belly and it also went away in a few days.
nurse accidentally splashed eye w/small droplet of varicella vax;eye burned a little, redness, blurred vision for short time, subsequently recovered;
Medial aspect of L thigh (inner thigh) redness 12.5cm x 7cm, swelling and warm to touch. No pain, no difficulty walking and no fever.
In the evening of 2/9/2023 I noticed a great deal of fatigue, body aches. Overnight I developed a fever and chills. Tested positive 2/10/23 on at home COVID-19 test and developed sore throat and sinus pressure with drainage. Treated symptomatically. Fever peaked at 103. After 2 days, symptoms gradually reduced, with fever broken that day. At day 14, the sinus pressure and drainage spiked with a feeling of pressure in the ears. Went to doctor for this and was diagnosed with sinus infection. Doctor prescribed antibiotics. After 10 days on antibiotics and FLONASE, everything returned to normal gradually. Dry cough lingers at time of reporting.
Fever, headache, stiff neck, hypotension, arm pain within 4 hours of vaccination with Fluzone High Dose -Lot UH488AC- Sanofi- admitted to her local hospital-had multiple normal cultures and LP - all no growth - needed Levophed for BP - Covered with IV Zosyn - fully recovered and discharged on Day 4.
YF Vax given 6/16/03, no others. Hx previous vaccine 1970's, current age 43 - complained of onset of headache 13 days post vaccine 6/29. Morning of 6/30 AM awoke with red bumpy rash face, forearms, slightly pruritic, "didn't feel normal", able to work. 7/2/03 feels more normal, rash less red and bumpy.
Shingles; Information has been received regarding a case in litigation, referring to a patient (pt) of unknown age. Concurrent condition, medical history and concomitant therapy were not reported.   In 2013 the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, frequency, lot#, expiration date not known) for long-term prevention of shingles and/or zoster-related conditions, administered by a healthcare provider at a hospital. Subsequently, on an unknown date, pt experienced shingles, and was treated by a healthcare provider. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX). Pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was reported as not recovered. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
She felt like if she had received a steroid shot. She was going 100 miles an hour. She felt very energized, she had excess of energy. She kept going and going and going.; This spontaneous case was reported by a patient and describes the occurrence of ENERGY INCREASED (She felt like if she had received a steroid shot. She was going 100 miles an hour. She felt very energized, she had excess of energy. She kept going and going and going.) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication.    Previously administered products included for Product used for unknown indication: Pfizer (Dose 1, Lot number: EN9581.) on 14-Jan-2021, Pfizer (Dose 2, Lot number: EL3246.) on 03-Feb-2021, Pfizer (Dose 3, Lot number: EW0175.) on 23-Aug-2021, Pfizer (Dose 4 and Lot number: FL3197.) on 27-Jan-2022. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Drug allergy (gluten). Concomitant products included ROSUVASTATIN for an unknown indication.   On 04-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (unknown route) 1 dosage form. On an unknown date, the patient experienced ENERGY INCREASED (She felt like if she had received a steroid shot. She was going 100 miles an hour. She felt very energized, she had excess of energy. She kept going and going and going.). At the time of the report, ENERGY INCREASED (She felt like if she had received a steroid shot. She was going 100 miles an hour. She felt very energized, she had excess of energy. She kept going and going and going.) had resolved.            No treatment medications was reported.
itching and rash (scalp, wrist ankles, arms), tingly feeling with lips/mouth
April 5th, one week after receiving the vaccine, I began to experience chills, extreme skin sensitivity, and ran a low-grade fever. This continued, with the skin pain worsening on the right side of my torso, until Thursday, April 8th, when a rash appeared on the right side of my stomach. By that night, I also had rash spots on my back (also the right side) and other small spots on my torso, with blisters starting to form on the patch on my stomach. The pain and rash were entirely on the right side of my torso. Friday morning (April 9th), I did a Telehealth visit and was diagnosed with shingles. I was prescribed an anti-viral which I began taking Friday evening. The symptoms began going away by Saturday afternoon and continue to heal. I finished the anti-virals course on Friday, April 16th, and as of today, April 19th, the rashes are almost all completely gone, I have no fever, and only a few small pain spots.
Five minutes after the Moderna COVID vaccine was administered via IM route patient began to have seizure like activity, bilateral pupil dilation, bounding pulse and uncontrollable body movements. EpiPen administered by nursing.
Pt received smallpox vaccination on 2/21/03, primary vaccination (3 jabs). Flu on 2/27/03, pt complained of headache, nausea, but nothing to keep him from missing work. 3/3/03 pt was seen for headache, dizziness, sore joints, fever, sore throat, constipation and rash. Was given Tylenol.  Pt was offered enema and glycerin suppository. Pt asked to wait on medication. Pt was to follow up next morning. During the night, pt went to the ER for increased abdominal pain and was diagnosed with constipation again. Pt was given enema and Golytly for constipation, along with quarters for 72 hours. Pt was seen in clinic on 3/6/03 for follow up. Pt's side effects from smallpox vaccine resolving as was his constipation. Pt was to return to work on 3/7/03.
Several lesions/spots inside (R) thigh, covering chest, some on head, arms and legs
administered with vaccine that experienced more than 1 temperature excursion; administered with vaccine that experienced more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 3:47 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 3:47 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of the patient was reported as 31.44.  Concomitant medication of the patient was not reported.  Batch number 031L20A underwent temperature excursion on 14-Feb-2021 with temperature of 32 degrees Fahrenheit at 09:00 AM, 10:00 AM and 11:00 AM respectively and 35 degrees Fahrenheit at 02:00 PM and 03:00 PM. These vials were moved to fridge on 09-Feb-2021 and beyond use date for the vials was reported as 10-Mar-2021. The vaccines moved to clinic on 13-Jan-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and  traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-566976 (Patient Link).
Itching and it looks like little red rash coming out at different parts of my body; little red rash coming out at different parts of my body; little red "patches; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on 04Aug2021 at 13:15 as single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received first Pfizer (Covid-19 vaccine) dose yesterday on 04Aug2021 at 1:15 in the afternoon and on 05Aug2021, in evening patient started itching and it looks like patient have (little red) rash coming out at different parts of body and patient was just wondering does that go away. Patient stated little red patches (further not clarified), patient just wondering does it goes away. The first 48 hours of the vaccine or do patient need to go to the hospital. The outcome of events was not recovered.  Follow-up activities closed. Batch/lot number not available for [vaccine/BNT162B2].
Information was received on 27-OCT-2016 from a medical assistant concerning a female patient of unknown age. No medical history or concomitant medications were reported. On 27-OCT-2016 the patient received a dose of PROQUAD (lot, dose and route not reported) and a dose of VARIVAX (lot, dose and route not reported) during an office visit. No adverse effect was reported. Additional information is not expected. Reporter did not give consent to contact physician.
Patient claims that she has had a significant amount of arm pain after the vaccine that has not subsided prior to her report date of 12/5/15.  Per her physician, she has described it as a dull, aching pain with swelling.
This spontaneous report as received from a pharmacist refers to an unspecified patients of unknown ages. On an unknown date, the patients were vaccinated with ZOSTAVAX, dose (unknown), frequency (unknown), for unknown indication. No concomitants were reported. Pharmacist reported that 50% of unspecified patients, who were administered with ZOSTAVAX at his pharmacy, developed redness at the injection site within 2 hours and an injection site rash. The outcome of events was unknown. Casualty assessment was not provided. VZV packet was not sent as patients were unspecified. NO further information was provided. This report is linked to 1402USA006792, 1402USA007825 and 1402USA007826 by the same reporter link. Additional information has been requested.
Adverse effect of other vaccines and biological substances, initial encounter on 2022-06-07.
At 7:10 AM on 8/24/21 Patient reported that her ICD was firing and that she would be going to the ED for evaluation.  After arriving at the ED Patient's husband reported that the Patient would be having a cardiac catheterization completed due to chest pain .  Around 11:10am on 08/24/21.  Husband reported following the cardiac catheterization that there was no new blockage identified, with fluid build up surrounding heart, the treatment was to provide diuretics with plan for the patient to remain in the hospital for at least 24 hours.  On 8/25/21 husband reported that the patient remained in the ICU for monitoring of output.  Cardiac defibrillator did not deliver any further shock (defibrillation).
I had no Reactions to the first three Moderna shots I took (series 1, series 2, booster). However, with this fourth shot (bivalent booster) I had strong flu like symptoms that night, including a fever.   What was worse, was I broke out in hives all over my back, legs, and chest. I?ve never had an allergic reaction before so I wasn?t sure what was happening. Very itchy. Also developed ?dermatographia? which I had never heard of or experienced before.   I?ve mostly been able to manage the hives by taking Zyrtec every night. Though I start to feel itchy as I near the 24 hour mark each night.   However, nothing seems to help the dermatographia. Slight pressure, heat, or soft touch all triggers my skin to turn red and produce itchy wheals. It?s been over a month now with no relief, so I will be going to urgent care soon (since I don?t have a primary care doctor). I really hope this isn?t a lifelong disorder from the Moderna booster.
Covid symptoms.  PT got 1st covid vaccine today around 1000. C/O migraine, dz, photophobia, nausea and subjective fever since 1400-1500. No v/d. No fever at this moment. PT did not take medication. Re-Assessment@ 0000: pt feeling better.  Pt has acute migraine-like symptoms but with reported fever/chills, also early viral meningitis-like symptoms.  Low clinical suspicion for bacterial sepsis, meningitis, or focal septic arthritis.  CRP and NLR both low and w/o objective fever.  Pt's symptoms overall not common from my limited experience with pts, after 1st dose of Moderna vaccine.  Discussed suspected vaccine-related side effects but told pt i couldn't r/o new viral early meningitis and discussed benefits/risks of L
Patient developed hives 1 hour after receiving vaccines on 1/26/15: mom was advised to give BENADRYL.
None at time of administration. MD and NP spoke to parent and made her aware of vaccine given in the wrong route.
E87.1 - Hypo-osmolality and hyponatremia D69.6 - Thrombocytopenia, unspecified
At 9:37am since vaccinated the staff gave the wrong kid the wrong vaccine. COVID Vaccine the 6month-4 yr old  Lot #: GW8170
pt recv vax 6AUG96 & 24APR97 pt was exposed to chickenpox;1MAY97 pt devel a sore throat & chickenpox;It was noted that body was covered w/lesions;pt presented to MD & recovered;
"Moderna COVID-19 vaccine EUA" Four hours after 2nd Moderna vaccine a raised  rash appeared on lower right side of face, then to chin, then to left side of lower jaw. Tingling of outer lips. Whole facial swelling. Fast heart beat four hours after that.
Vaccine administration error only, no adverse event. Pfizer COVID-19 [monovalent] vaccine administered instead of Pfizer COVID-19 [bivalent] vaccine as indicated.
This report describes the occurrence of an injection site reaction in a 20-month-old male who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  This report was received from the patient's mother and has not been verified by an physician or other health care professional.  The subject had no relevant medical history or concurrent conditions.  He received no concurrent medications.  He experienced no adverse effects following previous immunizations.  On 09/12/2002, the subject received his fourth injection of Infanrix (lot DTPA541A9; expiration date 09/2003).  On 09/13/2002, he experienced an injection site reaction characterized by swelling and redness.  Additionally, he experienced a fever of 102 degrees Fahrnheit.  As of 09/16/2002, the injection site reaction had "improved' and the fever persisted.